title: Targeting of highly conserved Dengue virus sequences with anti-Dengue virus trans-splicing group I introns.
abstract: BACKGROUND
  Dengue viruses (DENV) are one of the most important viral diseases in the world with approximately 100 million infections and 200,000 deaths each year. The current lack of an approved tetravalent vaccine and ineffective insecticide control measures warrant a search for alternatives to effectively combat DENV. The trans-splicing variant of the Tetrahymena thermophila group I intron catalytic RNA, or ribozyme, is a powerful tool for post-transcriptional RNA modification. The nature of the ribozyme and the predictability with which it can be directed makes it a powerful tool for modifying RNA in nearly any cell type without the need for genome-altering gene therapy techniques or dependence on native cofactors.
  
  
  RESULTS
  Several anti-DENV Group I trans-splicing introns (αDENV-GrpIs) were designed and tested for their ability to target DENV-2 NGC genomes in situ. We have successfully targeted two different uracil bases on the positive sense genomic strand within the highly conserved 5'-3' cyclization sequence (CS) region common to all serotypes of DENV with our αDENV-GrpIs. Our ribozymes have demonstrated ability to specifically trans-splice a new RNA sequence downstream of the targeted site in vitro and in transfected insect cells as analyzed by firefly luciferase and RT-PCR assays. The effectiveness of these αDENV-GrpIs to target infecting DENV genomes is also validated in transfected or transformed Aedes mosquito cell lines upon infection with unattenuated DENV-2 NGC.
  
  
  CONCLUSIONS
  Analysis shows that our αDENV-GrpIs have the ability to effectively trans-splice the DENV genome in situ. Notably, these results show that the αDENV-GrpI 9v1, designed to be active against all forms of Dengue virus, effectively targeted the DENV-2 NGC genome in a sequence specific manner. These novel αDENV-GrpI introns provide a striking alternative to other RNA based approaches for the transgenic suppression of DENV in transformed mosquito cells and tissues.
authors.affiliation: Eck Institute for Global Health, Department of Biology, University of Notre Dame, Notre Dame, IN 46556, USA.
authors.forename: James R
authors.initials: JR
authors.lastname: Carter
authors.forename: James H
authors.initials: JH
authors.lastname: Keith
authors.forename: Pradip V
authors.initials: PV
authors.lastname: Barde
authors.forename: Tresa S
authors.initials: TS
authors.lastname: Fraser
authors.forename: Malcolm J
authors.initials: MJ
authors.lastname: Fraser
mesh_terms: D000818:Animals; D001483:Base Sequence; D002460:Cell Line; D009033:Culicidae / Q000821:virology; D003715:Dengue / Q000235:genetics; D003716:Dengue Virus / Q000235:genetics*; D015870:Gene Expression; D016679:Genome, Viral; D006801:Humans; D007438:Introns; D008969:Molecular Sequence Data; D016337:RNA, Catalytic / Q000235:genetics*; D012367:RNA, Viral / Q000235:genetics*; D020040:Trans-Splicing
chemical_list: D016337:RNA, Catalytic; D012367:RNA, Viral